XLO XILIO THERAPEUTICS INC Investments/Divestments 8-K Filing 2024 - Stock Purchase Agreement with Gilead Sciences Xilio Therapeutics entered into a stock purchase agreement with Gilead Sciences, selling 6,860,223 shares of its common stock for $13.5 million.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC